Morellinol



Compound IDCDAMM01426
Common nameMorellinol
IUPAC name12-hydroxy-19-(4-hydroxy-3-methylbut-2-enyl)-8,8,21,21-tetramethyl-5-(3-methylbut-2-enyl)-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaene-14,18-dione
Molecular formulaC33H38O7

Experimental data

Retention time3.21
Adduct[M+H]+
Actual mz547.269
Theoretical mz547.269
Error0.04
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9087

Identifiers and class information

Inchi keyUWZMGTSPGQXAAP-ZDLGFXPLNA-N
SmilesO=C1C2=C(O)C=3C=CC(OC3C(=C2OC45C1=CC6C(=O)C5(OC(C)(C)C4C6)CC=C(C)CO)CC=C(C)C)(C)C
SuperclassOrganoheterocyclic compounds
ClassBenzopyrans

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)546.659
Computed dipole moment(dipole)3.019
Total solvent accessible surface area (SASA)823.54
Hydrophobic component of SASA (FOSA)564.216
Hydrophilic component of SASA (FISA)146.598
Pie component of the SASA (PISA)112.726
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1621.21
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)7.7
Free energy of solvation of dipole (dip^2/V)0.0056221
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0093499
Globularity descriptor (glob)0.810412
Predicted polarizability in cubic angstroms (QPpolrz)55.309
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.232
Predicted octanol/gas partition coefficient (QPlogPoct)24.126
Predicted water/gas partition coefficient (QPlogPw)10.97
Predicted octanol/water partition coefficient (QPlogPo/w)5.354
Predicted aqueous solubility (QPlogS)-7.185
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.115
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.137
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)403.376
Predicted brain/blood partition coefficient (QPlogBB)-1.346
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)185.426
Predicted skin permeability, log Kp (QPlogKp)-3.152
PM3 calculated ionization potential (IP(ev))8.991
PM3 calculated electron affinity (EA(eV))0.777
Number of likely metabolic reactions (#metab)9
Prediction of binding to human serum albumin (QPlogKhsa)1.188
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)79.016
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)106.468
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q07820MCL1Induced myeloid leukemia cell differentiation protein Mcl-1T14912SwissTargetPrediction
P11926ODC1Ornithine decarboxylaseT60366SEA
O15111CHUKInhibitor of NF-kappa-B kinase (IKK)T78429SwissTargetPrediction
P10599TXNThioredoxinT85616SwissTargetPrediction and SEA
P16233PNLIPPancreatic triacylglycerol lipaseT94309SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T14912DI0012Acute myeloid leukaemia[ICD-11: 2A60]Q07820MCL1
T14912DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]Q07820MCL1
T14912DI0250Mature B-cell lymphoma[ICD-11: 2A85]Q07820MCL1
T14912DI0252Melanoma[ICD-11: 2C30]Q07820MCL1
T14912DI0274Multiple myeloma[ICD-11: 2A83]Q07820MCL1
T14912DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q07820MCL1
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T78429DI0250Mature B-cell lymphoma[ICD-11: 2A85]O15111CHUK
T85616DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P10599TXN
T94309DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P16233PNLIP
T94309DI0308Obesity[ICD-11: 5B80-5B81]P16233PNLIP

Copyright © 2025